Last summer’s event broke new ground in many ways

Unnoticed by all but one of the small clutch of businessmen enjoying the light breeze pushing along the veranda of Hall 11, the bells of a distinctive Roman church to the West rang out to mark midday. AirPods and laptops left most of them oblivious. But to me, it was a brief moment of serene […]

How top brands are leading the march to Net Zero

The past decade has seen quite astounding advances in industry’s approach to sustainability, with many companies reporting that they’re not only on course to meet their net-zero targets, but are accelerating them by up to five years as they adopt ever-better practices. The halls of ACHEMA were awash with examples of how many of our […]

ACHEMA sets tone for a sustainable process industry

In June, 2,842 exhibitors from 56 nations showed 106,001 participants from 141 countries the latest equipment and innovative processes for the chemical, pharmaceutical and food processing industries at the Frankfurt exhibition grounds. Whether it was laboratory or pharmaceutical technology, plant engineering or classic process technology, the stands in the halls were very busy and at […]

The importance – and implications – of carbon capture

The chemical industry’s job of turning raw materials into chemicals for industrial and consumer use is vital for a strong global economy, writes Diana Garcia The International Energy Agency currently ranks the chemical sector as not on track to meet its CO2 emissions reduction targets. Direct CO2 emissions from primary chemical production remained relatively constant […]

How China is fast becoming a global pharma powerhouse

China city view at night

A groundswell of government support and an influx of western influence have helped to rapidly accelerate the sector There’s nothing new in the fact that pharmaceutical companies are working without borders, seeking to capitalise on technologies and resources anywhere in the world that advances a sector constantly moving forward in search of innovation. And, given […]

How ESG became top priority for pharma

The development of vaccines, treatments and tests has transformed attitudes to an industry not previously known for its approach to ESG. And with pressure from patients, customers and investors there’s a renewed impetus.

Hydrogen options – making the case for pink

There is a growing movement towards the development of nuclear hydrogen as well as a growing number of alternatives furthering the debate on whether to import or rely on home-grown solutions